INFUSYSTEM HOLDINGS, INC Lease, Cost
INFUSYSTEM HOLDINGS, INC (INFU) reported Lease, Cost of $603.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2026-08-04
- INFUSYSTEM HOLDINGS, INC lease, cost for the quarter ending 2026-06-30 was $603.00K, a 1.95% decline year-over-year.
- INFUSYSTEM HOLDINGS, INC lease, cost for the quarter ending 2026-03-31 was $589.00K, a 10.89% decline year-over-year.
- INFUSYSTEM HOLDINGS, INC lease, cost for the quarter ending 2025-12-31 was $562.00K, a 3.10% decline year-over-year.
- INFUSYSTEM HOLDINGS, INC lease, cost for the quarter ending 2025-09-30 was $611.00K, a 6.82% increase year-over-year.
- INFUSYSTEM HOLDINGS, INC lease, cost for fiscal 2025 was $2.45M, a 7.93% increase from fiscal 2024.
- INFUSYSTEM HOLDINGS, INC lease, cost for fiscal 2024 was $2.27M, a 23.32% increase from fiscal 2023.
- INFUSYSTEM HOLDINGS, INC lease, cost for fiscal 2023 was $1.84M, a 12.61% increase from fiscal 2022.
- INFUSYSTEM HOLDINGS, INC lease, cost for fiscal 2022 was $1.63M, a 4.81% increase from fiscal 2021.
| Period end | Lease, Cost 3 month | Lease, Cost 6 month | Lease, Cost 9 month | Lease, Cost 12 month |
|---|---|---|---|---|
| 2026-06-30 | $603.00K 10-Q · filed 2026-08-04 | $1.19M 10-Q · filed 2026-08-04 | $1.75M derived: sum of 3 quarters · filed 2026-08-04 | $2.37M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $589.00K 10-Q · filed 2026-05-08 | $1.15M derived: sum of 2 quarters · filed 2026-05-08 | $1.76M derived: sum of 3 quarters · filed 2026-05-08 | $2.38M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $562.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $1.17M derived: sum of 2 quarters · filed 2026-02-27 | $1.79M derived: sum of 3 quarters · filed 2026-08-04 | $2.45M 10-K · filed 2026-02-27 |
| 2025-09-30 | $611.00K 10-Q · filed 2025-11-04 | $1.23M derived: sum of 2 quarters · filed 2026-08-04 | $1.89M 10-Q · filed 2025-11-04 | $2.47M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $615.00K 10-Q · filed 2026-08-04 | $1.28M 10-Q · filed 2026-08-04 | $1.86M derived: sum of 3 quarters · filed 2026-08-04 | $2.43M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $661.00K 10-Q · filed 2026-05-08 | $1.24M derived: sum of 2 quarters · filed 2026-05-08 | $1.81M derived: sum of 3 quarters · filed 2026-05-08 | $2.38M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $580.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $1.15M derived: sum of 2 quarters · filed 2026-02-27 | $1.72M derived: sum of 3 quarters · filed 2026-02-27 | $2.27M 10-K · filed 2026-02-27 |
| 2024-09-30 | $572.00K 10-Q · filed 2025-11-04 | $1.14M derived: sum of 2 quarters · filed 2025-11-04 | $1.69M 10-Q · filed 2025-11-04 | $2.17M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $569.00K 10-Q · filed 2025-08-05 | $1.12M 10-Q · filed 2025-08-05 | $1.60M derived: sum of 3 quarters · filed 2025-08-05 | $2.07M derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | $548.00K 10-Q · filed 2025-05-08 | $1.03M derived: sum of 2 quarters · filed 2025-05-08 | $1.50M derived: sum of 3 quarters · filed 2025-05-08 | $1.96M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $481.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $956.00K derived: sum of 2 quarters · filed 2025-03-11 | $1.41M derived: sum of 3 quarters · filed 2025-03-11 | $1.84M 10-K · filed 2025-03-11 |
| 2023-09-30 | $475.00K 10-Q · filed 2024-11-08 | $931.00K derived: sum of 2 quarters · filed 2024-11-08 | $1.36M 10-Q · filed 2024-11-08 | $1.76M derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | $456.00K 10-Q · filed 2024-08-09 | $884.00K 10-Q · filed 2024-08-09 | $1.28M derived: sum of 3 quarters · filed 2024-08-09 | $1.70M derived: sum of 4 quarters · filed 2024-08-09 |
| 2023-03-31 | $428.00K 10-Q · filed 2024-05-09 | $825.00K derived: sum of 2 quarters · filed 2024-05-09 | $1.24M derived: sum of 3 quarters · filed 2024-05-09 | $1.66M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $397.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-10 | $816.00K derived: sum of 2 quarters · filed 2024-04-10 | $1.23M derived: sum of 3 quarters · filed 2024-04-10 | $1.63M 10-K · filed 2024-04-10 |
| 2022-09-30 | $419.00K 10-Q · filed 2023-11-09 | $834.00K derived: sum of 2 quarters · filed 2023-11-09 | $1.24M 10-Q · filed 2023-11-09 | $1.62M derived: sum of 4 quarters · filed 2024-04-10 |
| 2022-06-30 | $415.00K 10-Q · filed 2023-08-09 | $818.00K 10-Q · filed 2023-08-09 | $1.20M derived: sum of 3 quarters · filed 2024-04-10 | $1.57M derived: sum of 4 quarters · filed 2024-04-10 |
| 2022-03-31 | $403.00K 10-Q · filed 2023-05-09 | $784.00K derived: sum of 2 quarters · filed 2024-04-10 | $1.15M derived: sum of 3 quarters · filed 2024-04-10 | $1.56M derived: sum of 4 quarters · filed 2024-04-10 |
| 2021-12-31 | $381.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-10 | $748.00K derived: sum of 2 quarters · filed 2024-04-10 | $1.15M derived: sum of 3 quarters · filed 2024-04-10 | $1.56M 10-K · filed 2024-04-10 |
| 2021-09-30 | $367.00K 10-Q · filed 2022-11-08 | $773.00K derived: sum of 2 quarters · filed 2022-11-08 | $1.18M 10-Q · filed 2022-11-08 | $1.62M derived: sum of 4 quarters · filed 2023-03-16 |
| 2021-06-30 | $406.00K 10-Q · filed 2022-08-04 | $811.00K 10-Q · filed 2022-08-04 | $1.25M derived: sum of 3 quarters · filed 2023-03-16 | $1.73M derived: sum of 4 quarters · filed 2023-03-16 |
| 2021-03-31 | $405.00K 10-Q · filed 2022-05-05 | $846.00K derived: sum of 2 quarters · filed 2023-03-16 | $1.32M derived: sum of 3 quarters · filed 2023-03-16 | $1.80M derived: sum of 4 quarters · filed 2023-03-16 |
| 2020-12-31 | $441.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $915.00K derived: sum of 2 quarters · filed 2023-03-16 | $1.40M derived: sum of 3 quarters · filed 2023-03-16 | $1.93M 10-K · filed 2023-03-16 |
| 2020-09-30 | $474.00K 10-Q · filed 2021-11-15 | $955.00K derived: sum of 2 quarters · filed 2021-11-15 | $1.49M 10-Q · filed 2021-11-15 | $2.12M derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-06-30 | $481.00K 10-Q · filed 2021-08-12 | $1.02M 10-Q · filed 2021-08-12 | $1.65M derived: sum of 3 quarters · filed 2022-03-15 | $2.24M derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-03-31 | $536.00K 10-Q · filed 2021-05-10 | $1.17M derived: sum of 2 quarters · filed 2022-03-15 | $1.76M derived: sum of 3 quarters · filed 2022-03-15 | $2.10M derived: sum of 4 quarters · filed 2022-03-15 |
| 2019-12-31 | $632.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $1.22M derived: sum of 2 quarters · filed 2022-03-15 | $1.56M derived: sum of 3 quarters · filed 2022-03-15 | $2.24M 10-K · filed 2022-03-15 |
| 2019-09-30 | $589.00K 10-Q · filed 2020-11-13 | $932.00K derived: sum of 2 quarters · filed 2020-11-13 | $1.61M 10-Q · filed 2020-11-13 | |
| 2019-06-30 | $343.00K 10-Q · filed 2020-08-14 | $803.00K 10-Q · filed 2020-08-14 | ||
| 2019-03-31 | $462.00K 10-Q · filed 2020-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |